Decision impact and feasibility of different ASCO-recommended biomarkers in early breast cancer: Prospective comparison of molecular marker EndoPredict and protein marker uPA/PAI-1.
about
Decision impact and feasibility of different ASCO-recommended biomarkers in early breast cancer: Prospective comparison of molecular marker EndoPredict and protein marker uPA/PAI-1.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Decision impact and feasibilit ...... and protein marker uPA/PAI-1.
@en
Decision impact and feasibilit ...... and protein marker uPA/PAI-1.
@nl
type
label
Decision impact and feasibilit ...... and protein marker uPA/PAI-1.
@en
Decision impact and feasibilit ...... and protein marker uPA/PAI-1.
@nl
prefLabel
Decision impact and feasibilit ...... and protein marker uPA/PAI-1.
@en
Decision impact and feasibilit ...... and protein marker uPA/PAI-1.
@nl
P2093
P2860
P1433
P1476
Decision impact and feasibilit ...... t and protein marker uPA/PAI-1
@en
P2093
Christoph Petry
Evelyn Klein
Heinz Höfler
Katja Specht
Kirsten Grosse Lackmann
Laura Wolff
Marion Kiechle
Stefan Paepke
P2860
P304
P356
10.1371/JOURNAL.PONE.0183917
P407
P577
2017-09-06T00:00:00Z